Triple9 Friday, 09/29/17 09:19:33 AM Re: None Post # of 340 $SGMO hitting the investor circuits hard, first Cantor Fitzgerald and now "RICHMOND, Calif., Sept. 28, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer, will participate in the following conferences in October. 2017 Cell & Gene Meeting on the Mesa, La Jolla, CA, October 4-6, 2017 Dr. Macrae will participate in a panel discussion on gene editing at 9:15 a.m. PT on Thursday, October 5th, and is scheduled to present a company overview later that afternoon during the annual Partnering Forum at 2:15 p.m. PT. Jefferies Gene Technology Investor Summit, New York, NY, October 12, 2017 Dr. Macrae is scheduled to present a company overview at 2:50 p.m. ET on Tuesday, October 12th. The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. A replay of the presentations will be archived on the Sangamo website for two weeks after the event." Know What You Own. My posts should not be construed as investment advice.